Lantus, a new long-acting insulin

The FDA just approved Lantus, a new long-acting insulin from Aventis. It's also being considered in Canada.

Lantus is longer acting than NPH or Ultralente...and doesn't produce peak concentrations like other insulins.

Lantus is a synthetic insulin called insulin glargine. It differs from human insulin by 3 amino acids.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 120+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote